Skip to content

Pilot Study to Investigate Complaints, Wellbeing and Hormone Levels before and after Participation in a Hormone-Yoga Class for 10 Weeks

Pilot Study to Investigate Complaints, Wellbeing and Hormone Levels before and after Participation in a Hormone-Yoga Class for 10 Weeks - HoYoQoL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010733
Enrollment
50
Registered
2016-07-15
Start date
2016-07-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E28 N95

Interventions

Group 1: Quality of life of participants in a 10-week hormone-yoga class will be examined for the first time by questionnaires and hormone levels before, during and after the course

Sponsors

Universitätsklinikum HeidelbergAmbulanz für Naturheilkunde der Abt. Gynäkolog. Endokrinologie und Fertilitätsstörungen Universitätsfrauenklinik
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Registered participants with potentially hormone- related symptoms interested in learning a self- applicable method with potential influence on complaints, well-being and hormone levels of the course: Hormone-yoga class offered by the department Gynaecological Endocrinology and Fertility Disorders • Minimum age 18 years • Willingness for regular participation in 10 weekly lessons • Willingness for 2-6 self-initiated home practice sessions of 30 minutes/week during the duration of the course • Ability to provide informed consent • Sufficient knowledge of the German language in speech and writing • Willingness to complete the questionnaires

Exclusion criteria

Exclusion criteria: hormone-dependent tumors (breast cancer, endometrial cancer) • Undiagnosed genital bleeding • Untreated endometrial hyperplasia • Endometriosis • Fibroids of > 2 cm • Pregnancy • History of cosmetic breast surgery • Existing or past history of venous and/or arterial thromboembolic disease (especially deep vein thrombosis, pulmonary embolism, angina, myocardial infarction) • known thrombophilic disorders (especially protein C, protein S, or antithrombin deficiency) • previous heart surgeries, heart disease • acute glaucoma or prior glaucoma • Reduced resilient skeletal system, z. B. osteoporosis, bone metastases, inflammatory joint diseases • spinal disk disease • Undiagnosed abdominal discomfort, chronic appendicitis, which has not been operated • inflammation of the inner ear • Psychiatric problems, psychosis without adequate treatment

Design outcomes

Primary

MeasureTime frame
Changes of main symptoms and well-being as measured by the Measure Yourself Concerns and Wellbeing (MYCAW) and the WHO - 5 Index before and after participating in a 10-weeks class of hormone-yoga

Secondary

MeasureTime frame
Possible changes in hormone levels (FSH, LH, estradiol, TSH, T4, prolaktin, testosteron, DHEAS, progesteron during luteal Phase if applicable) before and after participating in a 10-weeks class of hormone-yoga

Countries

Germany

Contacts

Public ContactChristine Mahrla

Ambulanz für Naturheilkunde und Integrative MedizinAbt. Gynäkologische Endokrinologie und FertilitätsstörungenUniversitätsfrauenklinik Heidelberg

christine.mahrla@med.uni-heidelberg.de06221-567910

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026